Search
Mediwound Ltd
MDWDAdd to Watchlist
15.160USD
+0.340+2.29%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
194.84MMarket Cap
LossP/E TTM
More Details of Mediwound Ltd Company
Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues.; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.
Mediwound Ltd Info
Ticker SymbolMDWD
Company nameMediwound Ltd
IPO dateMar 20, 2014
CEOGonen (Ofer)
Number of employees111
Security typeOrdinary Share
Fiscal year-endMar 20
Address42 Hayarkon Street
CityYAVNE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code8122745
Phone972779714100
Websitehttps://www.mediwound.com/
Ticker SymbolMDWD
IPO dateMar 20, 2014
CEOGonen (Ofer)
Company Executives of Mediwound Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Ofer Gonen
Mr. Ofer Gonen
Chief Executive Officer, Director
Chief Executive Officer, Director
275.42K
+33.88%
Dr. Vickie R. Driver, M.D.
Dr. Vickie R. Driver, M.D.
Independent Director
Independent Director
--
--
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Independent Director
Independent Director
--
--
Dr. Ety Klinger, Ph.D.
Dr. Ety Klinger, Ph.D.
Chief Research and Development Officer
Chief Research and Development Officer
--
--
Mr. Yaron Meyer
Mr. Yaron Meyer
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
--
--
Mr. David Fox
Mr. David Fox
Independent Director
Independent Director
--
--
Mr. Jeremy Feffer
Mr. Jeremy Feffer
Managing Director
Managing Director
--
--
Mr. Shmuel (Milky) Rubinstein
Mr. Shmuel (Milky) Rubinstein
Independent Director
Independent Director
--
--
Dr. Shmulik Hess
Dr. Shmulik Hess
Chief Operating Officer, Chief Commercial Officer
Chief Operating Officer, Chief Commercial Officer
--
--
Ms. Hani Luxenburg
Ms. Hani Luxenburg
Chief Financial Officer
Chief Financial Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Ofer Gonen
Mr. Ofer Gonen
Chief Executive Officer, Director
Chief Executive Officer, Director
275.42K
+33.88%
Dr. Vickie R. Driver, M.D.
Dr. Vickie R. Driver, M.D.
Independent Director
Independent Director
--
--
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Independent Director
Independent Director
--
--
Dr. Ety Klinger, Ph.D.
Dr. Ety Klinger, Ph.D.
Chief Research and Development Officer
Chief Research and Development Officer
--
--
Mr. Yaron Meyer
Mr. Yaron Meyer
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
--
--
Mr. David Fox
Mr. David Fox
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Mediwound Ltd?
The top five shareholders of Mediwound Ltd are: Mr. Ofer Gonen
How many institutions hold shares of Mediwound Ltd (MDWD)?
As of 2026Q1, 165 institutions hold shares of Mediwound Ltd, with a combined market value of approximately 7.42M, accounting for 57.77% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 298423.00.